Colorado Regulators Recall Cannabis Products Due to Mold Contamination
Any consumer in possession of such a product has been advised by the Colorado Department of Revenue to return it to the initial retailer.
UK Regulator Grants Second Commercial License to Grow Medical Cannabis
The Jersey-based company has become the second cultivator in the British Isles to be licensed by the UK Home Office to grow pharmaceutical-grade cannabis for profit.
FDA Outlines Plan to Improve CBD Research Data
The administration said it intends to use poison control records and other databases to better identify CBD products associated with adverse events. A new opt-in registry for CBD consumers is also in the works.
Young Medical Cannabis Patients More Likely to Experience Withdrawal Symptoms, Finds Study
Following a two-year longitudinal study, the researchers concluded that cannabis withdrawal should be considered on a scale of severity, rather than as distinct subtypes of withdrawal syndromes.
Oregon Regulators Recall Pesticide-contaminated Cannabis Products
The adult-use cannabis extracts and pre-rolls initially failed state testing requirements and are considered unsafe for consumers.
Add-on CBD Reduces Seizures in Patients With Tuberous Sclerosis, Study Finds
The clinical trial found that Epidiolex can reduce the number of seizures in patients with tuberous sclerosis complex (TSC) by around 50 percent, compared to baseline levels.
Cannabis Reduces Stress in Female Rats, Study Finds
Female rats, who had been trained to inhale cannabis vapor daily, developed a blunted psychological response to stress, according to new research out of Washington State University.
Cannabinoid Research Center Launched in Denmark
QNTM Labs has announced a collaboration with the University of Southern Denmark to create the Global Cannabinoid Research Center in Odense, Denmark.
DEA Adds New Rule to Encourage Cannabis Research
The long-awaited rule should improve the quantity, quality, and accessibility of cannabis for scientific researchers in the US.
